Tyra Biosciences, Inc. (TYRA)
33.11
-0.48
(-1.43%)
USD |
NASDAQ |
May 27, 15:41
Tyra Biosciences Free Cash Flow : -102.47M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Spyre Therapeutics, Inc. | -185.87M |
| Relay Therapeutics, Inc. | -213.38M |
| Tango Therapeutics, Inc. | -142.55M |
| Entrada Therapeutics, Inc. | -131.64M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -32.57M |
| Cash from Investing (Quarterly) | -120.24M |
| Cash from Financing (Quarterly) | 160.38M |
| Free Cash Flow Per Share (Quarterly) | -0.5289 |
| Free Cash Flow to Equity (Quarterly) | -32.55M |
| Free Cash Flow to Firm (Quarterly) | -32.66M |
| Free Cash Flow Yield | -5.14% |